Last update April 15, 2024

ATC C10AA: Lipid Modifying Agents HMG CoA reductase inhibitors (Statins)

Rosuvastatin Calcium (belonging to ATC C10AA: Lipid Modifying Agents HMG CoA reductase inhibitors (Statins)):

Decreased level of risk

New scientific evidences have driven the Apilam staff to update the level of risk associated to this product.
Former level of risk, which was Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment., is now set to Safe. Compatible. Minimal risk for breastfeeding and infant.

Level of risk reviewed on April 10, 2024

Pravastatin Sodium (belonging to ATC C10AA: Lipid Modifying Agents HMG CoA reductase inhibitors (Statins)):

Decreased level of risk

New scientific evidences have driven the Apilam staff to update the level of risk associated to this product.
Former level of risk, which was Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment., is now set to Safe. Compatible. Minimal risk for breastfeeding and infant.

Level of risk reviewed on April 10, 2024

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Groups related with ATC C10AA: Lipid Modifying Agents HMG CoA reductase inhibitors (Statins)

Total visits

7,746

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by El Parto Es Nuestro of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM